Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 440

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 440
---
 book value to redemption amount value. The change in the carrying value of redeemable common stock resulted in charges against additional paid-in capital and accumulated deficit. As of September 30, 2024 and December 31, 2023, the common stock reflected on the condensed balance sheets are reconciled in the following table:

| ​ | Class A common stock subject to possible redemption as December 31, 2023  | ​ | ​ | ​ | $ |  4,049,650 | ​ | ​ |
| ​ | Less: Shares redeemed in March 2024                                       | ​ | ​ | ​ | ​ | -1,265,669 | ​ | ​ |
| ​ | Plus: Remeasurement of carrying value to redemption value                 | ​ | ​ | ​ | ​ |     86,389 | ​ | ​ |
| ​ | Class A common stock subject to possible redemption as March 31, 2024     | ​ | ​ | ​ | ​ |  2,870,370 | ​ | ​ |
| ​ | Plus: Remeasurement of carrying value to redemption value                 | ​ | ​ | ​ | ​ |     50,939 | ​ | ​ |
| ​ | Class A common stock subject to possible redemption as June 30, 2024      | ​ | ​ | ​ | ​ |  2,921,309 | ​ | ​ |
| ​ | Less: Shares redeemed in September 2024                                   | ​ | ​ | ​ | ​ |   -537,200 | ​ | ​ |
| ​ | Plus: Remeasurement of carrying value to redemption value                 | ​ | ​ | ​ | ​ |     68,054 | ​ | ​ |
| ​ | Class A common stock subject to possible redemption as September 30, 2024 | ​ | ​ | ​ | $ |  2,452,163 | ​ | ​ |

Warrants — Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues

F-17

TABLE OF CONTENTS

### IRIS ACQUISITION CORP

### NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of